Vsee Health (VSEEW) EBIT Margin (2023 - 2026)
On a quarterly basis, EBIT Margin fell 3898.0% to 94.12% in Q1 2026 year-over-year; TTM through Mar 2026 was 74.19%, a 44986.0% increase, with the full-year FY2025 number at 65.55%, up 53083.0% from a year prior.
Vsee Health's EBIT Margin history spans 4 years, with the latest figure at 94.12% for Q1 2026.
- EBIT Margin came in at 94.12% for Q1 2026, down from 87.61% in the prior quarter.
- The five-year high for EBIT Margin was 6.42% in Q1 2024, with the low at 1737.85% in Q3 2024.
- Historically, EBIT Margin has averaged 191.63% across 4 years, with a median of 54.7% in 2023.
- Biggest five-year swings in EBIT Margin: crashed -171320bps in 2024 and later soared 168616bps in 2025.
- Year by year, EBIT Margin stood at 7.74% in 2023, then tumbled by -948bps to 81.07% in 2024, then decreased by -8bps to 87.61% in 2025, then dropped by -7bps to 94.12% in 2026.
- Business Quant data shows EBIT Margin for VSEEW at 94.12% in Q1 2026, 87.61% in Q4 2025, and 51.69% in Q3 2025.
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -94.12% |
| Dec 31, 2025 | 78.15% |
| Sep 30, 2025 | -51.69% |
| Jun 30, 2025 | -66.51% |
| Mar 31, 2025 | -55.14% |
| Dec 31, 2024 | -81.07% |
| Sep 30, 2024 | -1,737.85% |
| Mar 31, 2024 | 6.42% |
| Dec 31, 2023 | -7.74% |
| Sep 30, 2023 | -24.64% |
| Jun 30, 2023 | -54.25% |
| Mar 31, 2023 | -45.38% |